Relationship among cystectomy, microvessel density and prognosis in stage T1 transitional cell carcinoma of the bladder

Journal of Urology

Volumn 160, Issue 4, 1998, Pages 1285-1290

  Dinney, Colin P N ^a   Babkowski, Robert C ^a   Antelo, Miguel ^a   Perrotte, Paul ^a   Liebert, Monica ^a   Zhang, Hua Zhong ^a   Palmer, Judy ^a   Veltri, Robert W ^a   Katz, Ruth L ^a   Barton Grossman, H ^a  

^a Box 110 ^*

Author keywords

Bladder; Carcinoma; Cystectomy; Neovascularization; Transitional cell

Indexed keywords

ADULT; ARTICLE; BLADDER CARCINOMA; CANCER STAGING; CANCER SURVIVAL; CYSTECTOMY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROVASCULATURE; NEOVASCULARIZATION (PATHOLOGY); OUTCOMES RESEARCH; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; TRANSITIONAL CELL CARCINOMA;

EID: 0032323157     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)62517-5     Document Type: Article

References (44)

1. Holmang, S., Hedelin, H., Anderstrom, C. and Johansson, S. L.: The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years. J. Urol., 153: 1823, 1995.
2. Amling, C. L., Thrasher, J. B., Frazier, H. A., Dodge, R. K., Robertson, J. E. and Paulson, D. F.: Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder. J. Urol., 151: 31, 1994.
3. Malkowicz, S. B., Nichols, P., Lieskovsky, G., Boyd, S. D., Huffman, J. and Skinner, D. G.: The role of radical cystectomy in the management of high grade superficial bladder cancer (PA P1, Pis and P2). J. Urol., 144: 641, 1990.
4. Eure, G. R., Cundiff, M. R. and Schellhammer, P. F.: Bacillus calmette-Guerin therapy for high risk stage T1 superficial bladder cancer. J. Urol., 147: 376, 1992.
5. Herr, H. W., Laudone, V. P., Badalament, R. A., Oettgen, H. F., Sogani, P. C., Freedman, B. D., Melamed, M. R. and Whitmore, W. F., Jr.: Bacillus Calmette-Guérin therapy alters the progression of superficial bladder cancer. J. Clin. Oncol., 6: 1450, 1988.
6. Cookson, M. S. and Sarosdy, M. F.: Management of stage T1 superficial bladder cancer with intravesical bacillus Calmette-Guerin therapy. J. Urol., 148: 797, 1992.
7. Frazier, H. A., Robertson, J. E. and Paulson, D. F.: Complications of radical cystectomy and urinary diversion: a retrospective review of 675 cases in 2 decades. J. Urol., 148: 1401, 1992.
8. Heney, N. M., Ahmed, S., Flanagan, M. J., Frable, W., Corder, M. P., Hafermann, M. D., Hawkins, I. R. for National Bladder Cancer Collaborative Group A: Superficial bladder cancer: progression and recurrence. J. Urol., 130: 1083, 1983.
9. Cordon-Cardo, C., Zhang, Z. F., Dalbagni, G., Drobnjaki, M., Charytonowicz, E., Hu, S. X., Xu, H. J., Reuter, V. E. and Benedict, W. F.: Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors. Cancer Res., 57: 1217, 1997.
10. Hasui, Y., Osada, Y., Kitada, S. and Nishi, S.: Significance of invasion to the muscularis mucosae on the progression of superficial bladder cancer. Urology, 43: 782, 1994.
11. Holmäng, S., Hedelin, H., Anderström, C., Holmberg, E. and Johansson, S. L.: The importance of the depth of invasion in stage T1 bladder carcinoma: a prospective cohort study. J. Urol., 157: 800, 1997.
12. Lacombe, L., Dalbagni, G., Zhang, Z. F., Cordon-Cardo, C., Fair, W. R., Herr, H. W. and Reuter, V. E.: Overexpression of p53 protein in a high-risk population of patients with superficial bladder cancer before and after bacillus Calmette-Guérin therapy: correlation to clinical outcome. J. Clin. Oncol., 14: 2646, 1996.
13. Sarkis, A. S., Dalbagni, G., Cordon-Cardo, G., Zhang, Z. F., Sheinfeld, J., Herr, H. W. and Reuter, V. E.: Detection of p53 mutations in superficial (T1) bladder cancer. Int. J. Cancer, 85: 53, 1993.
14. Lipponen, P. K.: Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value. Int. J. Cancer, 53: 365, 1993.
15. Sarkis, A. S., Barjorin, D. F., Reuter, V. E., Herr, H. W., Netto, G., Zhang, Z. F., Schultz, P. K., Cordon-Cardo, C. and Scher, H. I.: Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC. J. Clin. Oncol., 13: 1384, 1995.
16. Esrig, D., Kelmajian, D., Groshen, S., Freeman, J. A., Stein, J. P., Chen, S. C., Nichols, P. W., Skinner, D. G., Jones, P. A. and Cote, R. J.: Accumulation of nuclear p53 and tumor progression in bladder cancer. New Engl. J. Med., 331: 1259, 1994.
17. Cordon-Cardo, C., Wartinger, D., Petrylak, D., Dalbagni, G., Fair, W. R., Fuks, Z. and Reuter, V. E.: Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer. J. Natl. Cancer Inst., 84: 1251, 1992.
18. Logothetis, C. J., Xu, H. J., Ro, J. Y., Hu, S. X., Sahin, A., Ordonez, N. and Benedict, W. F.: Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer. J. Natl. Cancer Inst., 84: 1256, 1992.
19. Lipponen, P. K. and Liukkonen, T. J.: Reduced expression of retinoblastoma (RB) gene proteins is related to cell proliferation and prognosis in transitional-cell bladder cancer. J. Cancer Res. Clin. Oncol., 121: 44, 1995.
20. Folkman, J., Watson, K., Ingber, D. and Hanahan, D.: Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature, 339: 58, 1989.
21. Gimbrone, M. A., Jr., Leapman, S. B., Cotran, R. S. and Folkman, J.: Tumor dormancy in vivo by prevention of neovascularization. J. Exp. Med., 136: 261, 1972.
22. Gimbrone, M. A., Jr., Cotran, R. S., Leapman, S. B. and Folkman, J.: Tumor growth and neovascularization: an experimental model using the rabbit cornea. J. Natl. Cancer Inst., 52: 413, 1974.
23. Folkman, J. and Klagsburn, M.: Angiogenic factors. Science, 235: 442, 1987.
24. Weidner, N., Carroll, P. R., Flax, J., Blumenfeld, W. and Folkman, J.: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Amer. J. Path., 143: 401, 1993.
25. Srivastava, A., Laidler, P., Davies, R. P., Horgan, K. and Hughes, L. E.: The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study. Amer. J. Path., 133: 419, 1988.
26. Bosari, S., Lee, A. K., DeLellis, R. A., Wiley, B. D., Hyeatley, G. J. and Silverman, M. L.: Microvessel quantitation and prognosis in invasive breast carcinoma. Hum. Path., 23: 755, 1992.
27. Sillman, F., Boyce, J. and Fruchter, R.: The significance of atypical vessels and neovascularization in cervical neoplasia. Amer. J. Obst. Gynec., 139: 154, 1981.
28. Macchiarini, P., Fontanini, G., Hardin, M. J., Squartini, F. and Angeletti, C. A.: Relation of neovascularization to metastasis in non-small-cell lung cancer. Lancet, 340: 145, 1992.
29. Weidner, N., Carroll, P. R., Flax, J., Blumenfeld, W. and Folkman, J.: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Amer. J. Path., 143: 401, 1993.
30. Gasparini, G., Weidner, N., Maluta, S., Pozza, F., Boracchi, P., Mezzetti, M., Testolin, A. and Bevilacqua, P.: Intratumoral microvessel density and p53 protein: correlation with metastasis in head-and-neck squamous-cell carcinoma. Int. J. Cancer, 55: 739, 1993.
31. Jaeger, T. M., Weidner, N., Chew, K., Moore, D. H., Kerschmann, R. L., Waldman, F. M. and Carroll, P. R.: Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer. J. Urol., 154: 69, 1995.
32. Bochner, B. H., Cote, R. J., Weidner, N., Groshen, S., Chen, S. C., Skinner, D. G. and Nichols, P. W.: Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J. Natl. Cancer Inst., 87: 1603, 1995.
33. Dickinson, A. J., Fox, S. B., Persad, R. A., Hollyer, J., Sibley, G. N. and Harris, A. L.: Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas. Brit. J. Urol., 74: 762, 1994.
34. Crew, J. P., O'Brien, T. W. and Harris, A. L.: Bladder cancer angiogenesis, its role in recurrence, stage progression and as a therapeutic target. Cancer Metastasis Rev., 15: 221, 1996.
35. O'Brien, T., Cranston, D., Fuggle, S., Bicknell, R. and Harris, A.: Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res., 55: 510, 1995.
36. Mostofi, F. K., Sobin, H. L. and Torlini, H.: Histological typing of urinary bladder tumours. International Histologic Classification of Tumours, no. 10. Geneva: World Health Organization, 1973.
37. Collan, Y., Mäkinen, J. and Heikkinen, A.: Histological grading of transitional cell tumours of the bladder. Value of histological grading (WHO) in prognosis. Eur. Urol., 5: 311, 1979.
38. Kitadai, Y., Ellis, L. M., Takahashi, Y., Bucana, C. D., Anzai, H., Tahara, E. and Fidler, I. J.: Multiparametric in situ messenger RNA hybridization analysis to detect metastasis-related genes in surgical specimens of human colon carcinomas. Clin. Cancer Res., 1: 1095, 1995.
39. Serretta, V., Piazza, S., Pavone, C., Piazza, B. and Pavone-Maculoso, M.: Results of conservative treatment (transurethral resection plus adjuvant intravesical chemotherapy) in patients with primary T1, G3 transitional cell carcinoma of the bladder. Urology, 47: 647, 1996.
40. Bono, A. V., Benevenuti, C., Damiano, G. and Lovisolo, J.: Results of transurethral resection and intravesical doxorubicin prophylaxis in patients with T1G3 bladder cancer. Urology, 44: 329, 1994.
41. Cookson, M. S., Herr, H. W., Zhang, Z.-F., Soloway, S., Sogani, P. C. and Fair, W. R.: The treated natural history of high risk superficial bladder cancer: 15-year outcome. J. Urol., 158: 62, 1997.
42. Herr, H. W., Badalament, R. A., Amatu, D. A., Laudone, V. P., Fair, W. R. and Whitmore, W. F., Jr.: Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression. J. Urol., 141: 22, 1989.
43. Siitonen, S. M., Haapasalo, H. K., Rantala, I. S., Helin, H. J. and Isola, J. J.: Comparison of different immunohistochemical methods in the assessment of angiogenesis: lack of prognostic value in a group of 77 selected node-negative breast carcinomas. Mod. Path., 8: 745, 1995.
44. Van Hoef, M. E., Knox, W. F., Dhesi, S. S., Howell, A. and Schor, A. M.: Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur. J. Cancer, 29A: 1141, 1993.